<DOC>
	<DOC>NCT02606110</DOC>
	<brief_summary>The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.</brief_summary>
	<brief_title>Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<criteria>Patients with breast cancer referred to Physical Therapy for CIPN Physical Therapy Examination indicates use of Rebuilder for CIPN At least 18 years of age Signed informed consent for study population Willingness to complete study according to protocol Patients who do not have CIPN Patients &lt;18 years of age Inability to or unwilling to sign informed consent Unable to read and understand the English language Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>ReBuilder</keyword>
	<keyword>breast cancer</keyword>
	<keyword>chemotherapy induced</keyword>
</DOC>